are published in this issue of Toxicologic Pathology (2). We recognized that confusion over the terms &dquo;apoptosis&dquo; and &dquo;necrosis&dquo; stemmed from the fact that the recent dogma surrounding the meaning of these words did not fit with the everyday practical experience of toxicologic pathologists. The committee reached consensus on the fundamental ideas contained in these recommendations during our first meeting in Cincinnati, Ohio, on March 12, 1997. At a second meeting in Beaver Creek, Colorado, on June 25, 1997, we reviewed many histological alterations in various tissues via 35-mm transparencies to be sure that we were able to apply our recommendations with consistency to realworld examples. The manuscript went through several iterations before publication. During its development, it was submitted to more than 30 reviewers outside the Committee, including both STP members and nonmembers. The nonmember reviewers included pathologists, toxicologists, and cell biologists from around the world.
The recommendations of the Society of Toxicologic Pathologists (STP) ad hoc Committee on the Nomenclature of Cell Death are published in this issue of Toxicologic Pathology (2) . We recognized that confusion over the terms &dquo;apoptosis&dquo; and &dquo;necrosis&dquo; stemmed from the fact that the recent dogma surrounding the meaning of these words did not fit with the everyday practical experience of toxicologic pathologists. The committee reached consensus on the fundamental ideas contained in these recommendations during our first meeting in Cincinnati, Ohio, on March 12, 1997. At a second meeting in Beaver Creek, Colorado, on June 25, 1997, we reviewed many histological alterations in various tissues via 35-mm transparencies to be sure that we were able to apply our recommendations with consistency to realworld examples. The manuscript went through several iterations before publication. During its development, it was submitted to more than 30 reviewers outside the Committee, including both STP members and nonmembers. The nonmember reviewers included pathologists, toxicologists, and cell biologists from around the world.
Several reviewers expressed concerns that (a) introduction of this new system of nomenclature would confuse rather than clarify the current situation, (b) so many scientists have been trained in the dogma of an apoptosis-necrosis dichotomy that acceptance would be difficult, and (c) &dquo;oncosis&dquo; would inevitably be confused with neoplastic disease. These are serious but surmountable issues, yet no one challenged the scientific validity of the proposals. These concerns can be overcome by diligent educational efforts by STP as an organization and by each of us as its members. STP can promote the nomenclature by outreach programs that could include the production of a standard set of presentation slides that describe the proposals, encouraging members to present this nomenclature to other pathology and biology organizations and to trainees in pathology and toxicology, expecting authors of articles in Toxicologic Pathology to use the new nomenclature, and sending copies of the proposals to and encouraging their use by editors of other journals. Our responsibilities as individual STP members are to use the new nomenclature in our own studies, reports, and manuscripts (citing the Committee article when necessary), speak up within our own organizations whenever possible to make other scientists aware of the new paradigm, be willing to make the presentations to other organizations and training programs as mentioned above, and alert or challenge biologists in other disciplines through letters to the editors of various journals.
The STP Committee did not address the use or definition of the phrase &dquo;programmed cell death.&dquo; In an earlier editorial (1), I pointed out the confusion surrounding this phrase related to its different meanings to developmental biologists and cell physiologists, and I will not repeat the arguments here. Suffice it to say that this j phrase does not equate to apoptosis, and it is better left 1 unused in the context of toxicologic pathology. I am thankful that no one suggested we tackle this term.
Finally, I would like to express my personal distaste at equating apoptosis with cell &dquo;suicide.&dquo; For a person, suicide is a deliberate, conscious act. A single cell within a large organism cannot make deliberate decisions; it can merely react stereotypically to its microenvironment. Sometimes changes in this microenvironment trigger apoptosis. Once the process has been initiated, the cell is helpless to resist. Although the cell's organelles are involved in the process and energy may be used and proteins synthesized, it is not suicide. To equate apoptosis with suicide is like saying that a person or animal with some fatal disease, cancer for example, is committing suicide because the disease's progression requires the individual's own resources for energy production and protein synthesis.
Each of the committee members made significant contributions to the concepts embodied in the article and the manuscript itself. I thank all of its members for their contributions and patience during the process. It was a distinct privilege to have served as chairman.
